SEOUL, South Korea, Dec. 25, 2025 /PRNewswire/ -- ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for ...
-- Receiving Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform - Secured a total of 55 million in R&D funding, including 40 million in upfront payment and 15 ...
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback